1. 02 Characterising cardiovascular safety profile of muscarinic antagonist, ipratropium. Issue 1 (10th December 2010) Authors: Simmons, K; Khan, J; Hussain, A; Maddock, H L Journal: Heart Issue: Volume 97:Issue 1(2011) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 03 Cancer therapy drug, doxorubicin, exacerbates myocardial ischaemia reperfusion injury. Issue 1 (10th December 2010) Authors: Gharanei, A M; Hussain, A; Maddock, H L Journal: Heart Issue: Volume 97:Issue 1(2011) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 15 Mitochondrial Division Inhibitor-1 Protects against Doxorubicin-Induced Cardiotoxicity. (19th January 2014) Authors: Gharanei, M; Hussain, A; Janneh, O; Maddock, H L Journal: Heart Issue: Volume 100:(2014)Supplement 1 Page Start: A6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 20 Cardioprotection During Chemotherapy: A Case Study to Understand Intracellular Mechanisms to Combat the Cardiotoxicity of Sunitinib. (19th January 2014) Authors: Sandhu, H; Cooper, S; Eckert, M; Pisula, L; Chinweike, C; Gharanei, M; Maddock, H L Journal: Heart Issue: Volume 100:(2014)Supplement 1 Page Start: A7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 25 Acetylcholine protects against ipratropium induced myocardial injury. Issue 24 (24th November 2011) Authors: Simmons, K L; Hussain, A; Maddock, H L Journal: Heart Issue: Volume 97:Issue 24(2011) Page Start: e8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗